Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical... Tender

Procurement Summary

Country : USA

Summary : Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)

Deadline : 07 May 2021

Other Information

Notice Type : Tender

TOT Ref.No.: 22193412

Document Ref. No. : PA-18-741

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DEPT. OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH
Office of Administration 6011 Executive Boulevard, Room 538
City : Rockville
State : MD
Zip/Postal Code : 20892-7663
TEL : 301-435-4333
FAX : 301-402-1103

USA

Tender Details

Tender are invited for This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushings diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition; kidney, urologic, and hematologic diseases. The goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets or data, for which the primary goal is data analysis and not preparation/presentation of data.

Documents

 Tender Notice